MedTrace Logo

Endothelial Function Guided Therapy in Patients With Non-obstructive Coronary Artery Disease

NCT04013204 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2021-03-11

No results posted yet for this study

Summary

The purpose of this study is to systematically evaluate the clinical application value of vascular endothelial function examination in patients with non-obstructive coronary artery disease.

Conditions

  • Non-obstructive Coronary Artery Disease

Interventions

OTHER

Endothelial function guided therapy

To evaluate the effect of integration of non invasive endothelial function test (EFT) as a routine test in increasing appropriate treatment to reduce cardiovascular risk including prescription of lipid, blood pressure and glucose lowering medications by physicians at the clinic for patients with non-obstructive coronary artery disease (NOCAD) and the effect of introducing EFT as a routine test in reducing clinical endpoint (major adverse cardiovascular events) among patients with non-obstructive coronary artery disease(NOCAD).

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Peking University Shougang Hospital

    collaborator OTHER

  • Peking University

    lead OTHER

Principal Investigators

  • Hongyu Wang, MD · Peking University

  • Gaoqiang Xie, PHD · Peking University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-15
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04013204 on ClinicalTrials.gov